Systems Biology Approaches to Decoding the Genome of Liver Cancer

키워드

참고문헌 (64)

1. Parkin DM, "Global cancer statistics, 2002", CA Cancer J Clin, 55, pp.74~108 (2005)
2. Bruix J, "Focus on hepatocellular carcinoma", Cancer Cell, 5, pp.215~219 (2004)
3. Llovet JM, "Hepatocellular carcinoma", Lancet, 362, pp.1907~1917 (2003)
4. Thorgeirsson SS, "Molecular pathogenesis of human hepatocellular carcinoma", Nat Genet, 31, pp.339~346 (2002)
5. Lee JS, "Genome-scale profiling of gene expression in hepatocellular carcinoma: classification, survival prediction, and identification of therapeutic targets", Gastroenterology, 127(5 Suppl 1), pp.S51~S55 (2004)
6. Llovet JM, "Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials", Hepatology, 29, pp.62~67 (1999)
7. Calvet X, "Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients", Hepatology, 12(4 Pt 1), pp.753~760 (1990)
8. "A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators", Hepatology, 28, pp.751~755 (1998)
9. Kudo M, "Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)", J Gastroenterol, 38, pp.207~215 (2003)
10. Leung TW, "Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients", Cancer, 94, pp.1760~1769 (2002)
11. Faratian D, "Cancer systems biology", Methods Mol Biol, 662, pp.245~263 (2010)
12. Kreeger PK, "Cancer systems biology: a network modeling perspective", Carcinogenesis, 31, pp.2~8 (2010)
13. Sebolt-Leopold JS, "Mechanisms of drug inhibition of signalling molecules", Nature, 441, pp.457~462 (2006)
14. 정재연, "간세포암종의 표적치료제 Sorafenib", 대한소화기학회지, 52(4), pp.268~269 (2008), 대한소화기학회
15. Cheng AL, "Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial", LANCET ONCOLOGY, 10(0), pp.25~34 (2009), LANCET LTD, 84 THEOBALDS RD, LONDON, ENGLAND, WC1X 8RR
16. Abou-Alfa GK, "Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial", JAMA, 304, pp.2154~2160 (2010)
17. Nowell PC, "Chromosome studies on normal and leukemic human leukocytes", J Natl Cancer Inst, 25, pp.85~109 (1960)
18. Kallioniemi A, "Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors", Science, 258, pp.818~821 (1992)
19. Moinzadeh P, "Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade: results of an explorative CGH meta-analysis", Br J Cancer, 92, pp.935~941 (2005)
20. Kusano N, "Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features", Hepatology, 29, pp.1858~1862 (1999)
21. Zimonjic DB, "Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization", Hepatology, 29, pp.1208~1214 (1999)
22. Poon TC, "A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data", Gastroenterology, 131, pp.1262~1270 (2006)
23. Pinkel D, "Comparative genomic hybridization", Annu Rev Genomics Hum Genet, 6, pp.331~354 (2005)
24. Alizadeh AA, "Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling", Nature, 403, pp.503~511 (2000)
25. Bittner M, "Molecular classification of cutaneous malignant melanoma by gene expression profiling", Nature, 406, pp.536~540 (2000)
26. Lee JS, "Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling", Hepatology, 40, pp.667~676 (2004)
27. Beer DG, "Gene-expression profiles predict survival of patients with lung adenocarcinoma", Nat Med, 8, pp.816~824 (2002)
28. van 't Veer LJ, "Gene expression profiling predicts clinical outcome of breast cancer", Nature, 415, pp.530~536 (2002)
29. van de Vijver MJ, "A gene-expression signature as a predictor of survival in breast cancer", N Engl J Med, 347, pp.1999~2009 (2002)
30. Pinkel D, "High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays", Nat Genet, 20, pp.207~211 (1998)
31. Pollack JR, "Genome-wide analysis of DNA copy-number changes using cDNA microarrays", Nat Genet, 23, pp.41~46 (1999)
32. Sheehan KM, "Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma", Mol Cell Proteomics, 4, pp.346~355 (2005)
33. Espina V, "Protein microarrays: molecular profiling technologies for clinical specimens", Proteomics, 3, pp.2091~2100 (2003)
34. Haab BB, "Antibody arrays in cancer research", Mol Cell Proteomics, 4, pp.377~383 (2005)
35. Liotta LA, "Protein microarrays: meeting analytical challenges for clinical applications", Cancer Cell, 3, pp.317~325 (2003)
36. Davey JW, "Genome-wide genetic marker discovery and genotyping using next-generation sequencing", Nat Rev Genet, 12, pp.499~510 (2011)
37. Hoshida Y, "Gene expression in fixed tissues and outcome in hepatocellular carcinoma", N Engl J Med, 359, pp.1995~2004 (2008)
38. Woo HG, "Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma", Clinical Cancer Research, 14, pp.2056~2064 (2008)
39. Ye QH, "Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning", Nat Med, 9, pp.416~423 (2003)
40. Lee JS, "A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells", Nat Med, 12, pp.410~416 (2006)
41. Van Dyke T, "Cancer modeling in the modern era: progress and challenges", Cell, 108, pp.135~144 (2002)
42. Klausner RD, "Studying cancer in the mouse", Oncogene, 18, pp.5249~5252 (1999)
43. Lee JS, "Application of comparative functional genomics to identify best-fit mouse models to study human cancer", Nat Genet, 36, pp.1306~1311 (2004)
44. Lu L, "Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver", Proc Natl Acad Sci U S A, 통권 : 107, pp.1437~1442 (2010)
45. Lee KP, "The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 107통권 : 107, pp.8248~8253 (2010), National Academy of Sciences
46. Song H, "Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression", Proc Natl Acad Sci U S A, 통권 : 107, pp.1431~1436 (2010)
47. Zhou D, "Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene", Cancer Cell, 16, pp.425~438 (2009)
48. Ferrando AA, "Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia", Cancer Cell, 1, pp.75~87 (2002)
49. Eferl R, "Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53", Cell, 112, pp.181~192 (2003)
50. Hilberg F, "c-jun is essential for normal mouse development and hepatogenesis", Nature, 65, pp.179~181 (1993)
51. Logan CY, "The Wnt signaling pathway in development and disease", Annu Rev Cell Dev Biol, 20, pp.781~810 (2004)
52. Lee JS, "Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer", Hepatology, 35, pp.1134~1143 (2002)
53. Lee JS, "Comparative functional genomics for identifying models of human cancer", Carcinogenesis, 26, pp.1013~1020 (2005)
54. Lee JS, "Genetic profiling of human hepatocellular carcinoma", Semin Liver Dis, 25, pp.125~132 (2005)
55. Thorgeirsson SS, "Functional genomics of hepatocellular carcinoma", Hepatology, 43(2 Suppl 1), pp.S145~S150 (2006)
56. Thorgeirsson SS, "Molecular prognostication of liver cancer: end of the beginning", J Hepatol, 44, pp.798~805 (2006)
57. Thorgeirsson SS, "Genomic decoding of hepatocellular carcinoma", Gastroenterology, 131, pp.1344~1346 (2006)
58. Paris PL, "Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors", Hum Mol Genet, 13, pp.1303~1313 (2004)
59. Chin K, "In situ analyses of genome instability in breast cancer", Nat Genet, 36, pp.984~988 (2004)
60. Weiss MM, "Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival", Cell Oncol, 26, pp.307~317 (2004)
61. Carrasco DR, "High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients", Cancer Cell, 9, pp.313~325 (2006)
62. Rubio-Moscardo F, "Mantle- cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome", Blood, 105, pp.4445~4454 (2005)
63. Woo HG, "Identification of Potential Driver Genes in Human Liver Carcinoma by Genomewide Screening", CANCER RESEARCH, 69, pp.4059~4066 (2009), AMER ASSOC CANCER RESEARCH
64. Bruix J, "Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma", Hepatology, 42, pp.1208~1236 (2005)

관련 논문AI추천